Novartis Ag NVS
NYSE NVS
$161.75 -3.23 (-1.96%)
As of: Nov 5, 2026 · 3:59 PM EST

Novartis Ag (NVS) Liabilities and Shareholders Equity (2009 - 2026)

Updated

Analysis

Novartis Ag (NVS) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,221.09 Bn 1,194.71 Bn 20.46 Bn 148.07 Bn
2 Johnson & Johnson 656.38 Bn 576.24 Bn 17.30 Bn 197.43 Bn
3 AbbVie 510.79 Bn 478.80 Bn 13.12 Bn 147.68 Bn
4 Merck 363.00 Bn 317.38 Bn 12.21 Bn 129.80 Bn
5 Novartis Ag 313.89 Bn 287.12 Bn - -
6 Astrazeneca 290.02 Bn 263.91 Bn 13.26 Bn 119.92 Bn
7 Amgen 249.59 Bn 204.98 Bn 7.24 Bn 95.64 Bn
8 Gilead Sciences 208.15 Bn 183.26 Bn 6.73 Bn 51.41 Bn
9 Pfizer 170.74 Bn 118.10 Bn 12.56 Bn 205.00 Bn
10 Vertex Pharmaceuticals 137.20 Bn 109.19 Bn 2.91 Bn 32.74 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 122.03 Bn
Mar 31, 2026 118.53 Bn
Dec 31, 2025 110.95 Bn
Sep 30, 2025 107.29 Bn
Jun 30, 2025 104.40 Bn
Mar 31, 2025 99.94 Bn
Dec 31, 2024 102.25 Bn
Sep 30, 2024 103.52 Bn
Jun 30, 2024 97.51 Bn
Mar 31, 2024 94.33 Bn
Dec 31, 2023 99.95 Bn
Sep 30, 2023 112.70 Bn
Jun 30, 2023 110.98 Bn
Mar 31, 2023 112.24 Bn
Dec 31, 2022 117.45 Bn
Sep 30, 2022 118.46 Bn
Jun 30, 2022 122.91 Bn
Mar 31, 2022 125.22 Bn
Dec 31, 2021 131.80 Bn
Sep 30, 2021 121.21 Bn
API Access

Novartis Ag Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=NVS&period=max&api_key=YOUR_API_KEY